Research Results
Beta Version
Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.
Search by keyword
Select
Select
- All Risk Factors
- Air Pollution
- Alcohol
- Antimicrobials
- Artificial sweeteners
- Bisphenols
- Body Weight
- Breast Density
- Chemical Mixtures
- Chemicals in products
- Cleaning Products
- Diet
- Exercise
- Family History
- Furniture & Electronics
- Genetics
- Gut Health
- Hair Dye
- Hormones
- Inflammation
- Job
- Light at night
- Metals
- Neighborhood
- Night Shift Work
- Noise
- Non-stick Pans & Waterproof Gear
- Oral Contraceptives
- PAHs
- Parabens
- PCBs
- Personal Care Products
- Pesticides
- PFAS
- Pharmaceuticals
- Place-based
- Plastic
- Pregnancy & Breastfeeding
- Processed Food
- Puberty Age
- Race/Ethnicity
- Radiation
- Red meat
- Scented Products & Soft Plastic
- Sleeping Patterns
- Soda
- Stress
- Sugar
- Sunscreen
- Tobacco
- Vitamin D
Select
Select
Select
Select
Select the Chemical Agents
- All Chemical Agents
- 1,1,2,2-TCA
- 1,3-Butadiene
- Acrolein
- Aldrin
- Alkylphenols
- Antimicrobials
- Antimicrobials: QACs, Triclosan, Triclocarban
- Aromatic Amines
- Arsenic
- Artificial Sweeteners
- Atrazine
- Benzene
- Bisphenols
- Cadmium
- Chlordane
- Chlorpyrifos
- DDT
- Dibutyl Phthalate
- Dichlorvos
- Dieldrin
- Dioxins
- ell/
- Ethanol (alcohol)
- Ethyl Benzene
- Ethylene Oxide
- Flame Retardants
- Food
- Formaldehyde
- Glyphosate
- Heptachlor
- Hormones
- Insulin
- Lead
- Light at Night
- Mercury
- Metals
- Methoxyclor
- Naphthalene
- Night Shift Work
- Nitrogen Dioxide
- Noise
- Oral Contraceptives
- Organochlorine Pesticides
- Organophosphate Pesticides
- Ozone
- PAHs
- Parabens
- Particulate Matter
- PCBs
- Pesticides
- PFAS
- Phenols
- Phthalates
- Processed Food
- PVC
- Radiation: Ionizing
- Radiation: Non-Ionizing
- Soda
- Stress
- Sugar
- Tobacco
- Toluene
- Trichloroethylene
- Triclosan
- Ultraviolet Radiation
- UV Filters
- Vinyl Chloride
Select the Study Tags
Sort By
- Relevance
- Title (A to Z)
- Title (Z to A)
- Publication Year (Ascending)
- Publication Year (Descending)
- Authors (A to Z)
- Authors (Z to A)
2022
BMC Med
A large European study measuring inflammatory markers in the blood of over 3,000 women found that inflammation’s relationship with breast cancer risk differs dramatically by menopausal status, with higher levels of leptin and C-reactive protein (CRP) appearing protective in premenopausal women but associated with increased risk in postmenopausal women. The opposing effects were particularly evident for leptin and CRP, which showed 11-17% lower breast cancer risk in premenopausal women but 10-16% higher risk in postmenopausal women, and these associations were influenced by body weight. These findings suggest that inflammation and obesity may affect breast cancer development through different biological mechanisms before and after menopause, highlighting the importance of considering menopausal status when assessing breast cancer risk factors.
2021
Int J Clin Pract
A case-control study of 250 breast cancer patients and 250 controls found that women consuming diets that trigger higher insulin responses after meals—measured by dietary insulin index (DII) and dietary insulin load (DIL)—had 46-87% increased odds of breast cancer compared to those with lower scores. These high insulin-stimulating diets were more common among overweight women and those with family histories of cancer, suggesting that dietary patterns affecting blood insulin levels may be a modifiable risk factor for breast cancer. The findings support reducing consumption of foods that spike insulin levels—typically refined carbohydrates and high-glycemic foods—as a potential dietary strategy for breast cancer prevention, particularly for women at higher risk.
2025
Int J Environ Sci
This study investigated how DEHP (a common plastic additive) affects triple-negative breast cancer (TNBC), the most aggressive form of breast cancer. The researchers found that prolonged DEHP exposure enhanced cancer cell migration and invasion both in laboratory cultures and in animal models by activating a specific protein pathway involving MSI2, which promotes cancer spread and stem cell-like properties. DEHP exposure also reduced levels of a protective microRNA (miR-155-5p), while increasing MSI2 expression, suggesting these molecules work in opposition to each other. The findings identify MSI2 as a potential therapeutic target and prognostic marker for TNBC patients, providing new insights into how plastic additives may contribute to cancer metastasis.
2025
Sci Totl Environ
This study investigated the effects of three common plastic additives (DEHP, BPA, and benzotriazoles) on Atlantic cod liver tissue using precision-cut liver slices exposed to various concentrations of these chemicals individually and in mixtures. The researchers found that BPA and chemical mixtures caused estrogenic effects, significantly increasing vitellogenin (a female egg protein) production and related gene expression in male juvenile cod. The study also observed changes in liver metabolism genes, with mixture exposures showing potentially different effects than individual chemical exposures. The results suggest these plastic additives can disrupt hormone systems in fish, with BPA being the primary driver of estrogenic effects, though the interaction effects between chemicals require further investigation.
2025
J Hazard Mater
This study used advanced computer modeling to assess the combined reproductive health risks of phthalates (PAEs) and organophosphates (OPEs) found in atmospheric particles, focusing on their ability to disrupt hormone receptors. The researchers found that the mixed toxicity of these compounds was lower than expected from individual effects, suggesting they may interfere with each other’s toxic actions through antagonistic effects. Using network analysis and molecular modeling, they identified 590 potential targets and 50 core targets (including hormone receptors) affected by these pollutants, with DEHP, TPHP, and MEHP being key disruptors of hormone signaling pathways. The study also identified two previously overlooked targets (AKT1 and HSP90AA1) that may be important for reproductive toxicity, providing new insights into how these atmospheric pollutants may affect human reproductive health.
2023
Cancer Epidemiol Biomark Prev
A systematic review and meta-analysis of 34 observational studies and 3 Mendelian randomization studies found that women with the highest levels of C-reactive protein (CRP)—a marker of systemic inflammation—had a 13% increased breast cancer risk compared to those with the lowest levels, though the quality of evidence was rated as very low to moderate. While adiponectin showed a protective association (24% reduced risk), this finding was not supported by genetic evidence from Mendelian randomization studies, and there was little evidence that other inflammatory markers like TNFα and IL-6 affected breast cancer risk. These findings suggest that while chronic low-grade inflammation measured by CRP may modestly increase breast cancer risk, the overall role of inflammation in breast cancer development remains unclear, with limited support beyond CRP—highlighting the need for higher-quality prospective studies and mechanistic research to clarify whether inflammation is truly causal or merely a marker of other underlying processes that drive breast carcinogenesis.
2019
Environ Pollut
This study investigated how three endocrine-disrupting chemicals (BPA, BBP, and DEHP) affect estrogen receptor alpha (ERα) activity under normal and low-oxygen (hypoxic) conditions in breast and endometrial cancer cells. The researchers found that BPA and BBP activated ERα at specific concentrations, while DEHP did not, but all three chemicals enhanced ERα-mediated gene activity and decreased ERα protein levels under hypoxic conditions. BPA and BBP also affected hypoxia-related factors, decreasing hypoxia-inducible factor-1 activity while increasing VEGF (a blood vessel growth factor) secretion in breast cancer cells, whereas DEHP had different effects. The findings suggest that these endocrine disruptors can alter ERα regulation under low-oxygen conditions, which may influence disease processes since hypoxia is common in tumors and other pathological states.
2019
Environ Res
This study investigated how DEHP (a common plastic additive) and its metabolite MEHP affect breast cancer-related markers in T-47D breast cancer cells exposed to various concentrations for 4 days. The researchers found that high-dose DEHP (10,000 nM) and low-dose MEHP (0.1 nM) significantly increased cell proliferation without causing cell death, and DEHP also increased progesterone receptor (PR) protein levels and nuclear accumulation. When cells were treated with a progesterone receptor blocker (Mifepristone), the increased cell growth was completely prevented and PR nuclear levels were partially reduced, indicating that DEHP promotes breast cancer cell proliferation through progesterone receptor activation. The findings suggest that DEHP exposure may increase breast cancer risk by activating progesterone signaling pathways, though the exact mechanisms and long-term consequences require further investigation.
2019
Sci Rep
A case-control study of 1,050 breast cancer cases and 1,229 controls in which inflammatory markers (C-reactive protein and interleukin-6) were measured in 322 randomly selected case-control pairs examined whether dietary magnesium intake affects breast cancer risk directly and indirectly through inflammation. Higher magnesium intake was associated with 20% lower breast cancer risk (adjusted OR = 0.80; 95% CI: 0.65-0.99), while elevated CRP levels were associated with 43% increased risk (adjusted OR = 1.43; 95% CI: 1.02-2.01), though IL-6 showed no association with breast cancer. Path analysis revealed that dietary magnesium intake reduces breast cancer risk through two pathways: a direct protective effect and an indirect effect by lowering CRP levels, an inflammatory marker. These findings suggest that magnesium’s protective role against breast cancer operates both through anti-inflammatory mechanisms (by reducing systemic inflammation as measured by CRP) and through other direct biological pathways, highlighting the potential importance of adequate dietary magnesium intake for breast cancer prevention and the role of chronic inflammation in breast cancer development.
2018
Breast Cancer Res
A pooled analysis of three population-based case-control studies including 6,320 women (3,934 cases, 2,386 controls) aged 35-64 years examined whether the associations between body mass index (BMI) and breast cancer risk differ by tumor subtype defined by estrogen receptor (ER), progesterone receptor (PR), and HER2 status. Higher BMI at age 18 was inversely associated with premenopausal breast cancer risk across all ER/PR/HER2 subtypes (≥25 vs. <20 kg/m²: OR=0.72), with the strongest protection seen in premenopausal women who had high BMI both at age 18 and currently (46% reduced risk; OR=0.54; 95% CI: 0.38-0.78), while no significant associations were found for postmenopausal breast cancer. The findings indicate that high BMI during late adolescence provides similar protective effects against all molecular subtypes of premenopausal breast cancer regardless of hormone receptor or HER2 status, and this protection appears to be maximized when women maintain higher BMI consistently throughout their premenopausal years. These results suggest that the mechanisms by which adiposity protects against premenopausal breast cancer operate broadly across different tumor subtypes rather than being specific to hormone receptor-positive disease.
2022
Metabolites
This study investigates the effects of the insecticide chlorpyrifos on rice plants. High concentrations of chlorpyrifos inhibited growth, increased oxidative stress, and led to lipid peroxidation, as indicated by elevated malondialdehyde (MDA) levels. Antioxidant enzyme activities increased, and protein synthesis was negatively impacted. Significant changes in amino acids and organic acids, including increased proline and glutathione, were observed, suggesting a stress response. Just as chlorpyrifos induces oxidative stress in plants, similar mechanisms may occur in humans, leading to cellular damage and increasing the risk of chronic diseases such as cancer.
2018
Environ Int
A study analyzing 65 seafood samples (195 analyses including raw and cooked preparations) from 11 European countries for pharmaceuticals (PhACs) and endocrine-disrupting compounds (EDCs)—chemicals linked to reproductive system effects, metabolic disorders, breast cancer pathogenesis, and antimicrobial resistance—found that while pharmaceuticals were mostly undetectable, EDCs were quantified in the majority of samples, with cooking by steaming significantly increasing their levels 2- to 46-fold. Human exposure assessment focused on three prevalent EDCs (bisphenol A, methylparaben, and triclosan) revealed that the Spanish population had the highest exposure through seafood consumption among the 11 countries studied, though exposures remained below current toxicological reference values. These findings highlight that commercially available seafood in the European Union market contains detectable levels of endocrine-disrupting contaminants that concentrate during cooking, raising concerns about cumulative dietary exposure to these compounds through this widely consumed protein source, particularly in populations with high seafood consumption patterns.